Bendamustine as first-line treatment in patients with advanced indolent non-Hodgkin lymphoma and mantle cell lymphoma in German routine clinical practice.
about
Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation.Temsirolimus acts as additive with bendamustine in aggressive lymphoma.Altered treatment of chronic lymphocytic leukemia in Germany during the last decade.Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan.
P2860
Bendamustine as first-line treatment in patients with advanced indolent non-Hodgkin lymphoma and mantle cell lymphoma in German routine clinical practice.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Bendamustine as first-line tre ...... man routine clinical practice.
@ast
Bendamustine as first-line tre ...... man routine clinical practice.
@en
type
label
Bendamustine as first-line tre ...... man routine clinical practice.
@ast
Bendamustine as first-line tre ...... man routine clinical practice.
@en
prefLabel
Bendamustine as first-line tre ...... man routine clinical practice.
@ast
Bendamustine as first-line tre ...... man routine clinical practice.
@en
P2093
P2860
P1433
P1476
Bendamustine as first-line tre ...... man routine clinical practice.
@en
P2093
B Tschechne
U Schwinger
P2860
P304
P356
10.1007/S00277-015-2404-1
P577
2015-06-28T00:00:00Z